Recurrent pregnancy loss SUMC Soroka University Medical Center AIM To determine whether maternal history of recurrent pregnancy loss (RPL) impacts on the long-term neurological health of the offspring.
INTERPRETATION A history of maternal RPL appears to be independently associated with long-term neurological morbidity of the offspring.
Recurrent pregnancy loss (RPL), reported in 0.5% to 3% of couples trying to conceive, is now defined as two or more successive abortions before 20 weeks from the last menstrual period. In contrast to sporadic early pregnancy losses, the majority of which result from chromosomal abnormalities, RPL has a recognizable source in up to 50% of cases, other than the embryonic genetic make-up. Possible aetiologies for RPL include parental or embryonic chromosomal abnormalities, maternal background medical disorders (classically endocrine or autoimmune), congenital or acquired thrombophilias, toxic environmental exposures, and local uterine abnormalities. 1, 2 Females with a history of RPL have been found to be at an increased risk for preterm delivery and lower newborn infant Apgar scores, 3 both are independent and established risk factors for long-term neurological morbidity in the offspring. 4, 5 However, some common pathological pathways raise the possibility that a history of RPL may be independently associated with neurological childhood morbidity of the offspring.
Females with a history of RPL were found to have an increased risk for different long-term morbidities, including cardiovascular morbidities, 6 possibly due to an inherent systemic or a genetic aberration. A proposed underlying aetiology for this association involves less endothelium-independent vasodilatation related to both RPL and other morbidities later in life. 7 Endothelial dysfunction may cause placental hypoperfusion, leading to fetal hypoxia or placental oxidative stress and inflammation, 8 which may result in prenatal brain injury and cerebral palsy, 9 ,10 a sequence already reported in rats born preterm. 11 It is therefore possible that vascular aberrations in the uterine microenvironment, not necessarily leading to an abortion, impact fetal development and neurogenesis, and potentially disrupt the long-term cognitive or motor development of offspring to mothers suffering from RPL.
Several exposures have been shown to be associated with both maternal RPL and neurological development of the intrauterine exposed offspring. Examples include maternal environmental exposure to bisphenol A, reported to be associated with RPL, 12 as well as with emotional disorders (depression and anxiety) learning and attention deficits, and conduct disorders during childhood. 13 Another example involves imbalanced thyroid activity, a well-established aetiology for RPL. 1 Thyroid malfunction was found to insult the typically developing brain cells immigration early in embryonic development. Indeed, abnormally low or high maternal free thyroxin concentrations during pregnancy was found to be associated with lower child IQ and grey matter volume.
14 A recent example of a shared aetiology for RPL and offspring neurological development was published by our group and is related to maternal diabetes. Gestational diabetes exposure appears to be an independent risk factor for long-term neurological morbidity in the offspring and specifically to autism. 15 Others support this association. 16 These observations raise the possibility of a real and independent association between RPL and offspring neurological outcome, perhaps due to an abnormal intrauterine environment or maternal systemic illness. This association has not been previously studied. We therefore aimed, in the present study, to investigate the association between maternal background of RPL and the long-term neurological (including cognitive, motor, and mental) health of surviving children, up to the age of 18 years.
METHOD
In this population-based cohort analysis, all deliveries of singleton pregnancies occurring between January 1991 and January 2014 at the Soroka University Medical Center (SUMC) were included. SUMC is a regional tertiary centre, serving the entire population of the Negev (southern Israel), which constitutes 14.4% of Israel's inhabitants (approximately 1 220 000 people). 17 The study was approved by the local institutional review board (SUMC).
Detailed study methods are presented elsewhere. 18 In short, two databases were cross-linked and integrated: the computerized perinatal database of the SUMC Obstetrics and Gynecology Department, and the computerized paediatric hospitalization database of SUMC ('Demog-ICD9'). The perinatal database consists of information recorded immediately after delivery. The Demog-ICD9 database includes demographic information, as well as International Classification of Diseases, Ninth Revision (ICD-9) codes for all medical diagnoses made during any hospitalization at the SUMC.
Offspring of mothers who have experienced two previous sequential, or any three, spontaneous pregnancy losses up to 20 weeks' gestation (ICD-9 code V23.2) were considered exposed, 1 whereas all other offspring composed the comparison group. Multiple pregnancies, fetuses with congenital malformations, and all cases of perinatal mortality (intrauterine fetal death, intrapartum death, and post-partum death) were excluded from the longitudinal analysis.
A comparison of the neurological-related hospitalization rate, up to the age of 18 years, was performed, between children born to a mother with and without a history of RPL. Neurological morbidity was predefined by a paediatrician as one or more of the ICD-9 code list of diagnoses detailed in Table SI (online supporting information), which includes defined pathologies in different fields of paediatric neurology.
Follow-up time was defined as time to an event (first neurological-related hospitalization) or until censored. Censoring occurred in case of death, end of study period, or at age 18 years (which was calculated for each child based on their date of birth).
Statistical analysis was performed using SPSS version 23 (IBM, Armonk, NY, USA) and STATA software version 12.0 (StataCorp, College Station, TX, USA). Differences for categorical data were assessed by the v 2 test and are shown in counts and rates for general association. Student's t-tests were used for comparison of continuous variables with a normal distribution. The hospitalization incidence density rates were compared between the study groups in rates per 1000 person-years of follow-up, and hazard ratios (HRs) were calculated using Cox models for each and total neurological-related hospitalization among the study groups. Kaplan-Meier survival curves were used to compare cumulative hospitalization incidences over time in the exposed and comparison groups. The difference between survival curves was assessed using the log-rank test.
Owing to the lack of proportional relations of outcomes between groups, we chose the Weibull model for multivariable parametric analysis. This model establishes an independent association between maternal RPL background and future cumulative neurological hospitalization incidence in the offspring, while controlling for follow-up time, siblings (maternal clusters), and for other potential confounders. This approach is appropriate in accounting for family factors, such as genetics and environmental factors, which are shared by siblings in the cohort. Other confounders included factors that may have been independently related to both the exposure and the outcome, and/ or that we found to be significantly different between groups and clinically relevant. These included: (1) maternal ethnicity -due to a significant difference between the prevalence of different populations in the study cohort (Jews vs Bedouins) and potential ethnical and environmental differences between them, which might influence rates of neurological morbidity; (2) maternal diabetes mellitusa risk factor for RPL and for fetal central nervous system malformations; 19 (3) gestational age at delivery and 5-minute Apgar score of <7 -both of which may have a potential impact on neurological outcomes in offspring; 4,5 (4) mode of delivery -as there is an established association between neurological illness of the fetus (including cerebral palsy and epilepsy) and pathological presentations 20,21 -a common indication for surgical delivery. All analyses were two-sided, and a p-value of ≤0.05 was considered statistically significant.
What this paper adds
• Hospitalizations for epilepsy and developmental disorders are significantly more common among children of mothers with a history of recurrent pregnancy loss.
RESULTS
During the study period 242 187 deliveries met the inclusion criteria. Five per cent of the cohort (n=12 182) composed of the exposed group (mothers with RPL). The rest of the cohort (n=230 005) constituted the comparison, or 'no RPL', group.
Demographic characteristics and immediate perinatal outcomes of the different groups are presented in Table I . Pregnancies involving a history of RPL were more likely to occur in older mothers (31y and 3mo [standard deviation {SD} 5y and 9mo] vs 28y [SD 5y and 7mo]; p<0.001), with higher rates of hypertensive and diabetic disorders of pregnancy (6.4% vs 4.9% [p<0.001] and 9.4% vs 4.8% [p<0.001] respectively), and maternal hypothyroidism (1.4% vs 1%; p<0.001). Deliveries in the exposed group were more often preterm (9.8% vs 6.3%; p<0.001) and via Caesarean section (18.7% vs 13.2%; p<0.001). Rates of labour induction, sex of the offspring, and mean birthweight were comparable between the groups. Preterm deliveries occurred in 6.4% of the study population (mean 34.8wks [SD 1.8]). Of them, 1.6% occurred before 28 weeks of gestation, 14.3% between 29 to 33 weeks, and 84.2% after 34 weeks' gestation. Very early preterm delivery was significantly more prevalent in the group with RPL (p=0.02).
The incidence density of long-term neurological-related hospitalization in offspring, according to maternal RPL history, is shown in Table II The survival curves demonstrated significantly higher cumulative incidences of epilepsy and developmental disorder-related hospitalizations ( Fig. 1a,b ; log-rank p=0.009 and p<0.001 respectively).
The Weibull multivariable parametric survival model of long-term epilepsy and developmental disorders in offspring (up to the age of 18y) according to maternal history of RPL is presented in Tables III and IV Including chronic hypertension, gestational hypertension, and pre-eclampsia. RPL, recurrent pregnancy loss; SGA, small for gestational age. Including deliveries occurring between 24wks' and 36wks' gestation; entered into the model as a linear term (gestational age in wks). Additionally controlled for maternal clusters (siblings). aHR, adjusted hazard ratio; CI, confidence interval; RPL, recurrent pregnancy loss. Including pregestational and gestational diabetes.
c Including deliveries occuring between 24 wks' and 36 wks and 6 days' gestation; entered into the model as a linear term (gestational age in wks). Additionally controlled for maternal clusters (siblings). aHR, adjusted hazard ratio; CI, confidence interval; RPL, recurrent pregnancy loss. and adjusted HR 2.29 (95% CI 1.52-3.45) for developmental disorders.
DISCUSSION
In this large population-based cohort study, we suggest a significant association between maternal history of RPL and later childhood and adolescent neurological morbidity in the offspring. We found an increase of 23% in epilepsy rates and over a twofold increase in developmental disorder rates in the exposed group of offspring. The association remained significant while controlling for several potential confounders in the multivariable analysis, including gestational age and low Apgar scores.
We suspect these findings are the result of several possible explanations: (1) abnormal fetal development due to the abnormal uterine microenvironment in females with RPL; and/or (2) abnormal and potentially hereditary tendency for RPL also involved in brain function and development.
A hint for intrauterine processes, which influence embryonic and fetal development, may be found in the placenta. Inflammatory placental lesions, such as villitis of unknown aetiology, were reported to be associated with maternal immune intolerance for fetal structures resembling host versus graft rejection pathophysiology. Villitis of unknown aetiology was found to be associated with RPL, as well as pathological fetal brain development and cerebral palsy in newborn infants. 22 In one study, infants born at term diagnosed with neonatal encephalopathy all had placental lesions associated with villitis of unknown aetiology. The authors suggested that villitis of unknown aetiology may cause a local inflammatory response or oxidative stress during the perinatal period, which may induce white matter injury. 23 Autoimmunity, strongly associated with RPL, is another possible mechanism suggesting a hostile intrauterine microenvironment. 24 Antiphospholipid antibody syndrome is the hallmark of this phenomenon, with a well-established autoimmune pathogenesis leading to RPLs. 25 Other autoimmune disorders, such as systemic lupus erythematous, inflammatory bowel disease, autoimmune thyroiditis, coeliac disease, and even isolated elevated autoantibodies, were also found to be associated with higher RPL rates. 26 Adequate management, sometimes involving systemic steroids, may control abnormal immune processes and prevent losses. 27 However, maternal autoimmunity may also play a role in the neurological development of the offspring, as evident from studies focusing on maternal systemic autoimmune diseases and offspring neurological outcome. Maternal systemic lupus erythematous was shown to be associated with a spectrum of adverse developmental outcomes, including learning disabilities. 28 In another study, focusing on children who were diagnosed with developmental delay, maternal autoimmune disorder was 46% more common than in controls. 29 The authors suggested that under autoimmune flare-ups, fetal brain was subjected to an oxidative stress and to the direct effects of cytokines on neural development.
However, it may be that shared genetics or common autoimmune pathological pathways of mother and offspring are the explanation for both RPL in the mother and neurological morbidity in the child. Autoimmunity was recently reported to have a role in childhood seizures and epilepsy. Immune reactions may be involved in seizure aetiology via autoantibodies against various central nervous system targets (involved in neuronal activation) or when various central nervous system and peripheral immune responses are activated after seizures. 30 Increased rates of maternal diabetes in the group with RPL were evident in our cohort, as expected. These exposures were all proven to independently impact on the child's future health, and increase the risk for abnormal neurological development. 31 Thus, it may well be that this maternal background disorder leading to RPL also results in future offspring neurological morbidity, rather than an intrinsic aberrant uterine microenvironment or another explanation. Another potential bias is the higher rates of preterm delivery among patients with RPL. Rates of cerebral palsy and abnormal neurocognitive development are well known to be inversely related to gestational age. 4 In order to reduce the possibility that maternal morbidity or pregnancy complications were responsible for the increased rate of neurological morbidity in the offspring, a multivariable regression model adjusted for these factors and others was created (Tables III and IV ). The regression model showed that maternal RPL history was independently associated with a higher risk for future neurological morbidity in the offspring.
Notably, higher rates of low 5-minute Apgar score, known to be associated with poorer long-term neurological outcome, 5 were significantly more common in the comparison group, and thus cannot explain the association.
The absolute risk for epilepsy and developmental disorders in the large cohort presented is small. This might be the result of a relatively small effect, as well as due to the lack of ambulatory data on offspring. However, this may be a first signal of a possible association and is worth further investigation.
The main limitation of our study is its retrospective nature. Such studies may only suggest an association, rather than causation. Maternal RPL may serve only as a proxy to other maternal or pregnancy characteristics related to later neurological morbidity in the offspring and our findings, if real, may be caused by a number of different pathways. We included only hospitalized children suffering from a neurological condition. Cases handled in an ambulatory setting were not included in the analysis.
We followed children only up to 18 years of age. It is possible that other neurological abnormalities arise later in life. However, the vast majority of the studied neurological entities (including autism, and developmental, language, motor, and learning disorders), appear during childhood.
Significant differences in ethnicity between the groups could bias the results. We found a higher prevalence of epilepsy (0.83% vs 0.7%; p<0.001) and a higher prevalence of developmental disorders (0.12% vs 0.08%; p=0.001) in the Bedouin population. These findings may be explained in several ways, including mainly the inherent characteristics of the Bedouin population -a population in which low socio-economic status is common, as well as high parity and interfamily marriages. 32 In addition, higher rates of infectious diseases and nutritional deficiencies are reported, both of which may threaten typical childhood physical, motor, and cognitive development. 33, 34 Nevertheless, ethnicity (Jews vs Bedouins) was adjusted for in the multivariable model, yet the results remained unchanged (Tables III and IV) . Notably, the Israeli Jewish population underwent significant changes in the last few decades, with substantial mixing and interethnic marriages; thus, stratification by ethnic origin (i.e. Ashkenazi, Sephardic) was not possible. 35 Another limitation of the study is that the potential impact of maternal mental health disorders, possibly more common in the group with RPL 36 -neurological outcomes in offspring -could not be evaluated as data regarding maternal mental health were unavailable.
Low Apgar scores, found to be significantly more common in the comparison group, did not emerge as a risk factor for long-term neurological morbidity, in different multivariate models. In contrast to well-established data regarding the short-term prognostic value of a low Apgar score, 37 ,38 data regarding long-term implications of low Apgar score on later neurological health are controversial.
5,38-41
The study's large sample size, long follow-up period, and the significant and novel results contribute additional factors to be taken into account when counselling a patient with RPL. In addition, owing to the lack of proportional relations of outcomes between groups, as suggested by the Kaplan-Meier curves, we chose the Weibull model for multivariable parametric analysis over the Cox model. This model establishes an independent association between maternal RPL background and future cumulative neurological hospitalization incidence in the offspring, while controlling for follow-up time, siblings (maternal clusters), and for other potential confounders. This approach does not depend on proportional relations (as the Cox model does) and is appropriate in accounting for family factors, such as environment and genetics, which are shared by siblings in the cohort.
We thus conclude that a history of maternal RPL appears to be associated with an increased long-term risk for features of developmental disorders and childhood epileptic disorders in the offspring. These morbidities, some of which require intensive interventions within critical periods of early infancy and childhood, 42 may have a substantial impact on long-term personal well-being, lifespan, social function, associated morbidities, and lifetime health care expenditure. 43 These are preliminary findings. Prospective studies are needed to substantiate these findings and consider other causative pathways and potentially beneficial interventions.
